The liver cancer treatment depends on many factors including but not limited to the type of liver cancer, stage of the disease, liver function, performance status of the patient, along with other factors.
Following are the treatment options for hepatocellular carcinoma of the liver, but the final decision is taken by the oncologist on an individual patient basis.
|Potentially resectable or transplantable||In patients with potentially resectable liver cancer and adequate liver function, Surgery (partial hepatectomy) is considered the preferred treatment approach. For patients who are the candidates for liver transplantation, treatments like ablation or embolization may be employed until as a bridge for transplantation.|
|Unresectable||In patients with some advanced stage cancer that are considered unresectable due to invasion into blood vessels or large tumor size, treatments like ablation and/or embolization are generally preferred, depending on the location and the extent of invasion. Targeted therapy or chemotherapy may also be employed.|
|Inoperable with only local disease||In some cases, the tumor is limited to a part of the liver (which can be removed with surgery) but patients cannot have surgery due to poor liver function or performance status. Thus, treatments like ablation or embolization are usually employed in such cases. Targeted therapy or chemotherapy may also be considered.|
|Advanced (metastatic)||For patients with advanced liver cancer that has spread to distant body parts, targeted therapy or chemotherapy are generally considered.|
It is very important to assess the benefits of each treatment option versus the possible risks and side effects before making a treatment decision. Sometimes the patient’s choice and health condition are also important to make a treatment choice. Following are ultimate goals of treating liver cancer:
Join our liver cancer community to connect with fighters and survivors across the globe.
Join our community of fighters and survivors, motivate and uplift each other to fight cancer together.